FÜLÖPOVÁ, Nicole, Natalia CHOMOVA, Jan ELBL, Dagmar MUDRONOVA, Patrik SIVULIČ, Sylvie PAVLOKOVÁ and Aleš FRANC. Preparation and Evaluation of a Dosage Form for Individualized Administration of Lyophilized Probiotics. Pharmaceutics. Basel: MDPI, 2023, vol. 15, No 3, p. 1-19. ISSN 1999-4923. Available from: https://dx.doi.org/10.3390/pharmaceutics15030910.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Preparation and Evaluation of a Dosage Form for Individualized Administration of Lyophilized Probiotics
Authors FÜLÖPOVÁ, Nicole (703 Slovakia, belonging to the institution), Natalia CHOMOVA, Jan ELBL (203 Czech Republic, belonging to the institution), Dagmar MUDRONOVA, Patrik SIVULIČ (703 Slovakia, belonging to the institution), Sylvie PAVLOKOVÁ (203 Czech Republic, guarantor, belonging to the institution) and Aleš FRANC (203 Czech Republic, belonging to the institution).
Edition Pharmaceutics, Basel, MDPI, 2023, 1999-4923.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.400 in 2022
RIV identification code RIV/00216224:14160/23:00130704
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.3390/pharmaceutics15030910
UT WoS 000960126700001
Keywords in English lyophilization; antropozoonoses; probiotic bacteria; individual treatment; principal component analysis; viability of bacteria
Tags rivok, ÚFT
Tags International impact, Reviewed
Changed by Changed by: Mgr. Daniela Černá, učo 489184. Changed: 5/4/2024 07:41.
Abstract
Probiotics have been used in human and veterinary medicine to increase resistance to pathogens and provide protection against external impacts for many years. Pathogens are often transmitted to humans through animal product consumption. Therefore, it is assumed that probiotics protecting animals may also protect the humans who consume them. Many tested strains of probiotic bacteria can be used for individualized therapy. The recently isolated Lactobacillus plantarum R2 Biocenol™ has proven to be preferential in aquaculture, and potential benefits in humans are expected. A simple oral dosage form should be developed to test this hypothesis by a suitable preparation method, i.e., lyophilization, allowing the bacteria to survive longer. Lyophilizates were formed from silicates (Neusilin® NS2N; US2), cellulose derivates (Avicel® PH-101), and saccharides (inulin; saccharose; modified starch® 1500). They were evaluated for their physicochemical properties (pH leachate, moisture content, water absorption, wetting time, DSC tests, densities, and flow properties); their bacterial viability was determined in conditions including relevant studies over 6 months at 4 °C and scanned under an electron microscope. Lyophilizate composed of Neusilin® NS2N and saccharose appeared to be the most advantageous in terms of viability without any significant decrease. Its physicochemical properties are also suitable for capsule encapsulation, subsequent clinical evaluation, and individualized therapy.
Links
EF19_073/0016943, research and development projectName: Interní grantová agentura Masarykovy univerzity
MUNI/IGA/0942/2021, interní kód MUName: Formulation of dosage form with probiotics (Lactobacillus) for an oral administration (Acronym: FODPOA)
Investor: Masaryk University
PrintDisplayed: 29/7/2024 14:14